|
|
Education
| 1986** | University of Miami School of Medicine,
Miami, FL Medical Degree |
| 1981* | Pennsylvania State University, University
Park, PA Master Degree Exercise Physiology |
| 1978* | Oberlin College,
Oberlin. OH Undergraduate Major Psychobiology and Physical Education |
Post-Graduate Training:
| 1990-1991 | Faculty Development Fellowship University of Arizona College of Medicine Department of Family and Community Medicine, Tucson, AZ |
| 1987-1989*** | Residency in Family and Community Medicine Jackson Memorial Hospital, Miami, FL |
| 1986-1987 | Internship in Family Medicine Valley Medical Hospital, Fresno, CA |
Academic Appointments:
| 1991-present |
Faculty Member AIDS Education and Training Center University of Arizona College of Medicine, Tucson, AZ |
| 1991-1998 | Assistant Clinical Professor Department of Family and Community Medicine University of Arizona College of Medicine, Tucson, AZ |
| 1991-1993 | Clinical Assistant Professor Department of Internal Medicine, Section of Infectious Disease University of Arizona College of Medicine, Tucson, AZ |
| 1991-1993* | Attending Physician El Rio Health Center HIV Early Intervention Center, Tucson, AZ |
| 1990-1992 * | Attending
Physician University of Arizona Health Sciences Center Immune Deficiency Clinic, Tucson, AZ |
| 1990-1991 ** | Attending Physician University of Arizona Health Sciences Center Family Practice Clinic, Tucson, AZ |
| 1989-1990 *** | Clinical Assistant Professor University of Miami School of Medicine Department of Family Medicine and Community Health Miami, FL |
| 1989-1990 | AIDS Community Health Center
Liaison Physician Liberty City Community Health Center Dade County Area Health Education Council |
HIV/AIDS Research:
Principal Investigator: A Phase III Randomized, Double-Blinded, Placebo Controlled Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rhu GM-CSF) in Patients with Advanced HIV Disease. Protocol No. 001.0012
Principal Investigator: A Placebo-Controlled Evaluation of the effect of Chronic Testosterone Replacement Therapy (Testoderm: Testosterone Transdermal System) on Body Cell Mass and Body Weight in Hypogonadal Males with AIDS. Protocol No. C-95-012
Principal Investigator: An Open-Label, Continuation Study of Testoderm: Testosterone Transdermal System (CIII) in Hypogonadal males with HIV-Related Wasting. Protocol No. C-95-013
Principal Investigator: A 24-Week Phase II Multicenter, Randomized, Open-Label Study to Compare Antiretroviral Activity and Tolerability of Three Different Combination Regimens (DMP 266 + Indinauir, DMP 266 + Zidovudine + Lamivudine, Indinavir + Zidovudine + Lamivudine) in HIV-Infected Patients. Protocol No. DMP 266-006
Principal Investigator: A Randomized Phase IIIB Comparative Study to Evaluate Saquinavir Soft Gel Capsule (sgc) TID regimen in Combination with two NRTIs Versus Sacquinavir Soft Gel capsule (sgc) BID regimen in Combination with two NRTIs versus Saquinavir Soft Gel Capsule (sgc) BID plus Nelfinavir BID plus a NRTI in HIV-1 Infected Patients. Protocol No. NR 15520B
Principal Investigator: The Detection of Antibodies to HIV-1 in Specimens Obtained with the OraSure HIV-1 and the OraSure II HIV-1 Oral Specimen Collection Devices: Professional Use Study, Seropositive Collection. Protocol No. PS-069-Csp
Principal Investigator: Double-Blind Placebo-Controlled Study Comparing the Combination of 15% sp-303 Gel with Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects with Acquired Immunodeficiency Syndrome (AIDS). Protocol No. SP303T-A-04
